Proudly reporting that a significant part of Yasmin’s PhD work was recently published in the Eur. J. Immunol. Have a look at her work entitled “Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive” which informs on IL-10 co-expression in CAR-Treg cells providing an additional advantage to their intended suppressive capacity. Yasmin’s work provides an important proof-of-principle for this cell engineering approach for next-generation Treg therapy in transplantation.